KAILERA THERAPEUTICS, INC. COMMON STOCK
NASDAQ: KLRA (Kailera Therapeutics, Inc.)
Kemas kini terakhir: 2 jam lalu11.99
-0.84 (-6.55%)
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Kailera Therapeutics, Inc. | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 3.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 0.00 |
|
Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Bain Capital Investors Llc | 30 Jun 2026 | 26,255,581 |
| Bain Capital Life Sciences Investors, Llc | 30 Jun 2026 | 22,583,268 |
| Canada Pension Plan Investment Board | 30 Jun 2026 | 7,304,688 |
| Atlas Venture Life Science Advisors, Llc | 30 Jun 2026 | 5,171,282 |
| Adage Capital Partners Gp, L.L.C. | 30 Jun 2026 | 3,208,286 |
| Siren, L.L.C. | 30 Jun 2026 | 2,214,286 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |